Posaconazole Injection, Solution
Product Images NDC 68462-904

This is a description of a pharmaceutical product called Posaconazole Injection. Each vial contains 300 mg of posaconazole in a 16.7 mL solution. Each mL of the solution contains 18 mg of posaconazole. The inactive ingredients include betadex sulfobutyl ether sodium, edetate disodium dihydrate, hydrochloric acid, and sodium hydroxide. The product is distributed by Glenmark Pharmaceuticals Inc. in the USA and is a product of India. The product requires further dilution before intravenous use and should be stored refrigerated at 2°C-8°C. The diluted solution can be stored for up to 24 hours. The product is in a single-dose vial and any unused portion should be discarded. Additional dosing information can be found in the prescribing information.*

Glenmark is a pharmaceutical company that operates globally. They focus on the research, development, and manufacturing of generic and branded pharmaceutical products. With a strong presence in various therapeutic areas, Glenmark aims to improve patients' lives by providing affordable and effective medications. They have a diverse portfolio of products, including formulations, active pharmaceutical ingredients (APIs), and biologics. Glenmark is committed to innovation and expanding access to quality healthcare worldwide.*